Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Lechner

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
MMW Fortschritte Der Medizin|June 19, 2025
[Asymptomatic "hypothyroidism" in the elderly - what to consider?]Benjamin Lechner, Christian Lottspeich
Atherosclerosis|April 23, 2026
Plaque regression: Risk status or ApoB exposure?Katharina Lechner, Benjamin Lechner, Oliver Weingärtner
British Journal of Sports Medicine|March 7, 2020
Your athlete-patient has a high coronary artery calcification score-'Heart of Stone'. What should you advise? Is exercise safe?Katharina Lechner, Bianca Spanier, Benjamin Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|October 19, 2017
[Dietary Recommendations in Metabolic Vascular Syndrome]Katharina Lechner, Nicole Erickson, Benjamin Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2019
[Dementia and Metabolic-Vascular Risk Factors: Strategies for Prevention]Ulrike Gonder, Clemens von Schacky, Nicolai Worm, et al.
Scientific Reports|April 16, 2021
Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistanceKatharina Lechner, Benjamin Lechner, Alexander Crispin, et al.
European Journal of Endocrinology|July 13, 2019
THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronismBenjamin Lechner, Katharina Lechner, Daniel Heinrich, et al.
Current Hypertension Reports|September 5, 2019
Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a ReviewFinn Holler, Daniel A Heinrich, Christian Adolf, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2021
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trialKatharina Lechner, Johannes Scherr, Elke Lorenz, et al.
Journal of Clinical Medicine|August 12, 2023
De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF PatientsMatthias Bock, Clemens von Schacky, Johannes Scherr, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
MMW Fortschritte Der Medizin|June 19, 2025
[Asymptomatic "hypothyroidism" in the elderly - what to consider?]Benjamin Lechner, Christian Lottspeich
Atherosclerosis|April 23, 2026
Plaque regression: Risk status or ApoB exposure?Katharina Lechner, Benjamin Lechner, Oliver Weingärtner
British Journal of Sports Medicine|March 7, 2020
Your athlete-patient has a high coronary artery calcification score-'Heart of Stone'. What should you advise? Is exercise safe?Katharina Lechner, Bianca Spanier, Benjamin Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|October 19, 2017
[Dietary Recommendations in Metabolic Vascular Syndrome]Katharina Lechner, Nicole Erickson, Benjamin Lechner, et al.
Deutsche Medizinische Wochenschrift (1946)|August 28, 2019
[Dementia and Metabolic-Vascular Risk Factors: Strategies for Prevention]Ulrike Gonder, Clemens von Schacky, Nicolai Worm, et al.
Scientific Reports|April 16, 2021
Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistanceKatharina Lechner, Benjamin Lechner, Alexander Crispin, et al.
European Journal of Endocrinology|July 13, 2019
THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronismBenjamin Lechner, Katharina Lechner, Daniel Heinrich, et al.
Current Hypertension Reports|September 5, 2019
Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a ReviewFinn Holler, Daniel A Heinrich, Christian Adolf, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 28, 2021
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trialKatharina Lechner, Johannes Scherr, Elke Lorenz, et al.
Journal of Clinical Medicine|August 12, 2023
De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF PatientsMatthias Bock, Clemens von Schacky, Johannes Scherr, et al.
Pageof 2